LDHA and breast carcinoma: Oxamate, an inhibitor of LDHA, combined with paclitaxel-induced apoptosis in paclitaxel-resistant breast carcinoma (MDA-MB-435 and MDA-MB-231) cells by inhibiting cellular glycolysis (107).